Here are three stocks with buy rank and strong income characteristics for investors to consider today, September 9:Diversified Energy Company PLC (DEC) : This independent oil and gas company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.6% the last 60 days.This Zacks Rank #1 company has a dividend yield of 10.5%, compared with the industry average of 0.0%.AXIS Capital Holdings Limited (AXS) : This insurance company has witnessed the Zacks Consensus Estimate for its c ...

Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 9:AXIS Capital Holdings Limited (AXS) : This insurance company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.AXIS Capital Holdings Limited has a price-to-earnings ratio (P/E) of 7.16 compared with 15.60 for the industry. The company possesses a Value Score of A.G-III Apparel Group, Ltd. (GIII) : This appa ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the Company’s New Drug Application (NDA) for AXS-07 for the acute treatment of migraine. The FDA designated the resubmission as a Class 2 resubmission and set a Prescription Drug User Fee Act ...

Investors looking for stocks in the Insurance - Property and Casualty sector might want to consider either Axis Capital (AXS) or Cincinnati Financial (CINF) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Styl ...

For those looking to find strong Finance stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Axis Capital (AXS) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.Axis Capital is a member of our Finance group, which includes 860 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 ...

A month has gone by since the last earnings report for Axis Capital (AXS) . Shares have added about 3.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Axis Capital due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. AXIS Capital Q2 Earnings Beat on Solid UnderwritingA ...

Shares of AXIS Capital Holdings (AXS) have rallied 38.4% year to date, compared with the industry’s increase of 26.2%, the Finance sector’s rise of 13.4% and the Zacks S&P 500 composite’s rise of 18.2%. With a market capitalization of $2.8 billion, the average volume of shares traded in the last three months was 0.5 million.A compelling and diversified product portfolio, underwriting excellence, digital capabilities and solid capital position continue to drive the Zacks Rank #1 (Strong Buy) specialty and gl ...

The Zacks Insurance industry is undervalued than the Zacks S&P 500 composite and the Zacks Finance sector. The insurance industry’s price-to-book (the best multiple for valuing insurers because of their unpredictable financial results) of 1.57 was less than the Zacks S&P 500 composite’s P/B of 8.57 and the sector’s P/B of 3.65. Such below-market positioning hints at room for an upside in the days ahead.Image Source: Zacks Investment ResearchImage Source: Zacks Investment ResearchThus, before their valuation ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 19th:UCB (UCBJF) : This biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.9% over the last 60 days.UCB’s shares gained 25.5% ...